Advertisement

U.S. markets open in 3 hours 42 minutes

S&P Futures
4,308.25
-9.50(-0.22%)
Dow Futures
33,927.00
-116.00(-0.34%)
Nasdaq Futures
14,019.00
+32.25(+0.23%)
Russell 2000 Futures
1,908.80
-19.50(-1.01%)
Crude Oil
86.89
+0.28(+0.32%)
Gold
1,790.50
-4.50(-0.25%)

Advertisement

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - NYSE Delayed Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

8.23

-0.18

(-2.14%)

At close: 04:00PM EST

8.25

+0.02

(+0.24%)

Pre-Market:

04:05AM EST

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

Triple Moving Average Crossover

View all chart patterns

Performance Outlook

Previous Close	8.41
Open	8.42
Bid	0.00 x 2200
Ask	0.00 x 1800
Day's Range	8.22 - 8.51
52 Week Range	7.73 - 13.30
Volume	7,021,120
Avg. Volume	10,059,077

Market Cap	9.437B
Beta (5Y Monthly)	1.30
PE Ratio (TTM)	12.47
EPS (TTM)	0.66
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	Nov 27, 2017
1y Target Est	11.36

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Undervalued

11% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for TEVA

Learn more

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Teva Pharmaceutical Industries
Analyst Report: Teva Phar Inds LtTeva Pharmaceutical Industries Ltd. is the world's largest generic pharmaceutical manufacturer, with roughly 120 billion tablets and capsules produced annually. The company has over 37,000 employees and a presence in 60 countries. One of every 12 generic prescriptions in the U.S. is filled with Teva products.
Rating
Fair Value
Economic Moat
yesterdayArgus Research

All

News

Press Releases

Research Reports

Motley Fool
2 Best Warren Buffett Value Stocks to Buy Right Now
Berkshire Hathaway CEO Warren Buffett is one of the most successful value investors of all time. Although classic value stocks fell out of favor during the nearly decade-long bull market over the course of 2010 to 2020, and Berkshire's stock underperformed some major U.S. stock indexes as a result, these tried and true investing vehicles are making a furious comeback during this current bear market. The long and short of it is that the increasing likelihood of rising interest rates and stubbornly high levels of inflation ought to favor Buffett's value-oriented approach to investing over narrative-driven growth stocks in 2022.
- 11 Ways Warren Buffett Lives Frugally
  GOBankingRates
- 2 Charts That Show Why Investors Might Be More Conservative in 2022
  Motley Fool
Insider Monkey
10 Best Stocks to Buy Today According to Value Investor David Abrams
In this piece, we will take a look at the 10 best stocks to buy today according to value investor David Abrams. If you want to take a look only at the top five stocks in this list then head on over to 5 Best Stocks to Buy Today According to Value Investor David Abrams. […]
Motley Fool
3 Turnaround Stocks That Can Bounce Back Big Time in 2022
If we strictly looked at the performance of the major U.S. stock indexes, 2021 was a great year. While no investor enjoys seeing their stocks go in reverse, patience has a way of paying off handsomely in the stock market. In 2022, the following trio of turnaround stocks have the catalysts needed to bounce back in a big way.